Cutera Long Term Debt 2010-2024 | CUTR
Cutera long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Cutera Annual Long Term Debt
(Millions of US $) |
| 2023 |
$419 |
| 2022 |
$416 |
| 2021 |
$134 |
| 2020 |
$4 |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Cutera Quarterly Long Term Debt
(Millions of US $) |
| 2024-09-30 |
$420 |
| 2024-06-30 |
$420 |
| 2024-03-31 |
$419 |
| 2023-12-31 |
$419 |
| 2023-09-30 |
$418 |
| 2023-06-30 |
$418 |
| 2023-03-31 |
$417 |
| 2022-12-31 |
$416 |
| 2022-09-30 |
$300 |
| 2022-06-30 |
$300 |
| 2022-03-31 |
$134 |
| 2021-12-31 |
$134 |
| 2021-09-30 |
$134 |
| 2021-06-30 |
$134 |
| 2021-03-31 |
$134 |
| 2020-12-31 |
$4 |
| 2020-09-30 |
$7 |
| 2020-06-30 |
$7 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.007B |
$0.212B |
|
Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.
|
